Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07301411) titled 'Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tianjin Puli Ark Medical Technology Co., Ltd.
Condition:
Lung Malignancies
Intervention:
Device: Cryoablation Therapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: November 21, 2025
Target Sample Size: 40
Countries of Recruitment:
China
Hong Kong
China
Hong Kong
To know more, visit https://clinical...